Hossein Goudarzi

Hossein Goudarzi

Auto-generated profile, based on publicly available information

Hossein Goudarzi

Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 December 2018 in Reviews in Medical Virology
Verified
Journal Article
Closed access
JCJavad Charostad
Javad Charostad
AAAkram Astani
Akram Astani
HGHossein Goudarzi
Hossein Goudarzi
EFEbrahim Faghihloo
Ebrahim Faghihloo

13 December 2025 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
JSJavad yasbolaghi Sharahi
Javad yasbolaghi Sharahi
HGHossein Goudarzi
Hossein Goudarzi
ZGZohreh Ghalavand
Zohreh Ghalavand
MGMehdi Goudarzi
Mehdi Goudarzi
MJMohsen Javidi
Mohsen Javidi
AHAli Hashemi
Ali Hashemi
An alert has been issued regarding the widespread emergence of multidrug-resistant (MDR) and carbapenem-resistant Klebsiella pneumoniae (CRKP) in hospital

1 January 2026 in BioMed Research International
Verified
Journal Article
Open access
ZRZohreh Riahi Rad
Zohreh Riahi Rad
HGHossein Goudarzi
Hossein Goudarzi
MGMehdi Goudarzi
Mehdi Goudarzi
MJMohsen Javidi
Mohsen Javidi
JSJavad yasbolaghi Sharahi
Javad yasbolaghi Sharahi
AHAli Hashemi
Ali Hashemi
Background: According to the World Health Organization 2024 bacterial priority pathogens list, carbapenem‐resistant Enterobacterales (CRE) were listed among the critical priority pathogens. Heteroresistance (i.e., a bacterial isolate that appears susceptible but harbors resistant subpopulations) represents a challenge in traditional laboratory testing, which may lead to treatment failure with colistin. This phenomenon has been studied in many bacteria, including K. pneumoniae . To our knowledge, this is the first report of colistin heteroresistance in K. pneumoniae isolates using population analysis profiles (PAPs) in Iran. Methods: Between 2019 and 2020, 100 K. pneumoniae isolates were collected from various samples of hospitalized patients in Iran. This study primarily determined antibiotic resistance by antimicrobial susceptibility testing. Thereafter, the prevalence of colistin heteroresistance in K. pneumoniae isolates was evaluated by the PAP test. Heteroresistant isolates were typed by multilocus sequence typing (MLST). Results: The MIC test showed that 79 (79%) of the 100 K. pneumoniae isolates were susceptible to colistin. Overall, 2/79 colistin‐susceptible isolates were classified as heteroresistant isolates by the PAP method, with a colistin MIC of 0.5 μ g/ml. Importantly, after 5 serial passaging on colistin‐free plates, there was no increase in the MIC of the colistin‐resistant subpopulations, showing that heteroresistance cases were unstable. MLST revealed that heteroresistant isolates belong to ST377 and ST15. Conclusions: In conclusion, the current study contributes to our understanding of the challenges posed by heteroresistant isolates in clinical laboratories. Since heteroresistant isolates may be misidentified as susceptible by standard tests, these findings raise concerns regarding the interpretation of colistin susceptibility results.